Authors: HORSTMANN M KROSCHKE G STOCKSCHLADER M BETKER R KRUGER W ERTTMANN R KABISCH H ZANDER A

Citation: M. Horstmann et al., EARLY TOXICITY OF INTENSIFIED CONDITIONING WITH ETOPOSIDE COMBINED WITH TOTAL-BODY IRRADIATION CYCLOPHOSPHAMIDE OR BUSULFAN CYCLOPHOSPHAMIDE IN CHILDREN UNDERGOING AUTOLOGOUS OR ALLOGENEIC BONE-MARROW TRANSPLANTATION, Pediatric hematology and oncology, 13(1), 1996, pp. 45-53

Authors: STOCKSCHLADER M KRUGER W KROSCHKE G ZELLER W HOFFKNECHT M LOLIGER C KABISCH H ZANDER A

Citation: M. Stockschlader et al., USE OF CRYOPRESERVED BONE-MARROW IN ALLOGENEIC BONE-MARROW TRANSPLANTATION, Bone marrow transplantation, 15(4), 1995, pp. 569-572

Authors: KRUGER W STOCKSCHLADER M RUSSMANN B BERGER C HOFFKNECHT M SOBOTTKA I KOHLSCHUTTER B KROSCHKE G KROGER N HORSTMANN M KABISCH H ZANDER AR

Citation: W. Kruger et al., EXPERIENCE WITH LIPOSOMAL AMPHOTERICIN-B IN 60 PATIENTS UNDERGOING HIGH-DOSE THERAPY AND BONE-MARROW OR PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION, British Journal of Haematology, 91(3), 1995, pp. 684-690

Authors: STOCKSCHLADER M KRUGER W ZELLER W KROSCHKE G HOFFKNECHT M KABISCH H ZANDER A

Citation: M. Stockschlader et al., EFFECT OF CRYOPRESERVED DONOR BONE-MARROW ON ENGRAFTMENT AND GVHD IN ALLOGENEIC BONE-MARROW TRANSPLANTATION, Blood, 84(10), 1994, pp. 10000722-10000722